An ‘off-the-shelf’ fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

T cell malignancies represent a group of hematologic cancers with high rates of relapse and mortality in patients for whom no effective targeted therapies exist. The shared expression of target antigens between chimeric antigen receptor (CAR) T cells and malignant T cells has limited the development...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leukemia
Main Authors: Cooper, Matthew L., Choi, Jaebok, Staser, Karl, Ritchey, Julie K., Devenport, Jessica M., Eckardt, Kayla, Rettig, Michael P., Wang, Bing, Eissenberg, Linda G., Ghobadi, Armin, Gehrs, Leah N., Prior, Julie L., Achilefu, Samuel, Miller, Christopher A., Fronick, Catrina C., O’Neal, Julie, Gao, Feng, Weinstock, David M., Gutierrez, Alejandro, Fulton, Robert S., DiPersio, John F
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6102094/
https://ncbi.nlm.nih.gov/pubmed/29483708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-018-0065-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados